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Abstract
Background: Disturbed peripheral negative regulation might contribute to evolution of autoimmune insulitis in type 1
diabetes. This study evaluates the sensitivity of naı ¨ve/effector (Teff) and regulatory T cells (Treg) to activation-induced cell
death mediated by Fas cross-linking in NOD and wild-type mice.
Principal Findings: Both effector (CD25
2, FoxP3
2) and suppressor (CD25
+, FoxP3
+) CD4
+ T cells are negatively regulated by
Fas cross-linking in mixed splenocyte populations of NOD, wild type mice and FoxP3-GFP tranegenes. Proliferation rates and
sensitivity to Fas cross-linking are dissociated in Treg cells: fast cycling induced by IL-2 and CD3/CD28 stimulation improve
Treg resistance to Fas-ligand (FasL) in both strains. The effector and suppressor CD4
+ subsets display balanced sensitivity to
negative regulation under baseline conditions, IL-2 and CD3/CD28 stimulation, indicating that stimulation does not perturb
immune homeostasis in NOD mice. Effective autocrine apoptosis of diabetogenic cells was evident from delayed onset and
reduced incidence of adoptive disease transfer into NOD.SCID by CD4
+CD25
2 T cells decorated with FasL protein. Treg
resistant to Fas-mediated apoptosis retain suppressive activity in vitro. The only detectable differential response was
reduced Teff proliferation and upregulation of CD25 following CD3-activation in NOD mice.
Conclusion: These data document negative regulation of effector and suppressor cells by Fas cross-linking and dissociation
between sensitivity to apoptosis and proliferation in stimulated Treg. There is no evidence that perturbed AICD in NOD mice
initiates or promotes autoimmune insulitis.
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Introduction
Eruption of autoimmune insulitis in NOD mice has been
attributed to multiple aberrations of immune homeostasis [1,2],
including suboptimal control of effector cells (Teff) [3–5], deficient
activity of regulatory T cells (Treg) [6–10] and dysfunctional
interaction between these subsets [10–13]. Within the multiple
physiological mechanisms of immune homeostasis, negative
regulation of expanding clones is a dominant factor in determi-
nation of the cellular composition of inflammatory infiltrates. This
homeostatic mechanism relies on activation induced cell death
(AICD) mediated primarily by the Fas/Fas-ligand (FasL) interac-
tion as the common executioner of apoptosis within the tumor
necrosis factor (TNF) superfamily [14]. The relative sensitivity of
naı ¨ve/effector and suppressor T cells to AICD-type negative
regulation has been evaluated as a possible cause of immune
dysfunction in type 1 diabetes. T cells isolated from NOD mice are
generally more resilient to AICD, including both CD4
+ [15] and
CD8
+ T subsets [16], a characteristic that becomes more
accentuated with age [17]. Similar insensitivity to spontaneous
and Fas-mediated apoptosis has been observed in thymocytes of
the NOD mice [18], suggesting an inherent deficit in negative
regulation of effector T cells. These data led to the concept that
decreased susceptibility of pathogenic cells to AICD-type regula-
tion predisposes NOD mice to autoimmune insulitis and affects
disease progression.
Addressing the question how differential sensitivities of
diabetogenic and regulatory cells to apoptosis affects the evolution
of autoimmunity, conflicting evidence has been reported in NOD
mice and humans, ranging from resistance [19–21] to excessive
susceptibility [22–24] of Treg to AICD. Most studies have used
isolated cell populations disregarding the significant impact of
reciprocal interactions between effector and suppressor T cells on
sensitivity to apoptosis [19,25]. For example, IL-2 supplied by
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[26] and TCR-associated stimulation protects putative Treg from
apoptosis [19,24]. Consistent wit the observation that CD25
+ cells
are sensitized to FasL in mixed cultures of isolated subsets [19], we
have recently demonstrated that the isolation process dominates
the sensitivity to spontaneous apoptosis, which deviates substan-
tially from the behavior in mixed cultures [27]. In this study we
address two questions: a) whether NOD mice display intrinsic
variations in susceptibility to AICD that might contribute to
evolution of the autoimmune reaction, and b) what are the relative
responses of effector and suppressor CD4
+ T cells to AICD under
stimulation, considering that the patterns of cell death are
modulated under continuously changing inflammatory environ-
ments [28]. We found no significant differences in Fas-mediated
apoptosis between wild type and NOD mice that suggest
participation of aberrant negative regulation in evolution of
autoimmune insulitis. Although IL-2, TCR-associated activation
and costimulation modulate the sensitivity of both effector and
suppressor subsets to apoptosis, there is no evidence of perturbed
AICD homeostasis in mice with ongoing autoimmune insulitis.
Results
Sensitivity of naı ¨ve/effector CD4
+ subsets to Fas cross-
linking
Similar to high rates of spontaneous apoptosis in cultures of
isolated CD25
+ T cells from wild type mice [19], we have recently
documented excessive susceptibility to spontaneous apoptosis of
CD25
+ T cells isolated from diabetic NOD mice, which is reversed
by cytokines and cell-to-cell interactions in mixed splenocyte
cultures [27]. In variance from comparable levels of spontaneous
apoptosis, the composition of the culture affects the sensitivity of
various CD4
+ T cell subsets to FasL: apoptosis measured by
differential gating in mixed splenocyte cultures exceeds by far the
sensitivity to FasL recorded in isolated subsets (p,0.005,
Figure 1A). Although such arbitrary culture conditions are far
from simulating the microenvironment in which Treg operate at
the site of inflammation [28], mixed cultures appear to better
reflect the sensitivity to negative regulation than purified cell
subsets.
It has been suggested that relative resistance of naı ¨ve/effector T
cells to Fas cross-linking affects the evolution of the autoimmune
reaction in NOD mice [15–17]. Comparative analysis of apoptosis
in gated subsets within mixed populations of splenocytes and
lymph node cells shows similar sensitivity of CD25
2 T cells from
NOD mice to spontaneous and Fas-mediated apoptosis as the
CD25
2 and FoxP3
2 subsets in wild type mice (Figure 1B),
suggesting that evolution of inflammatory insulitis is not caused by
intrinsic deficits in AICD. Likewise, CD25
+ and FoxP3
+ T cells in
wild type mice display similar high sensitivities to Fas cross-linking
(Figure 1C), indicating that regulatory subsets are submitted to
AICD-type negative regulation. The similar levels of apoptosis of
CD25
+ T cells from NOD mice indicate that, like effector cells,
there is no apparent difference in negative regulation. Taken
together, these data show that both effector and suppressor T cells
are equally submitted to AICD-type negative regulation in wild
type and NOD mice.
Treg sensitivity to apoptosis under IL-2 stimulation
IL-2 is a significant cytokine involved in amplification of
cytotoxic T cell activity and is pivotal to the development and
function of Treg, which modulates the sensitivity of lymphocytes to
Fas-dependent and Fas-independent apoptosis [28]. The signifi-
cance of Treg in sustaining self-tolerance and their dependence on
IL-2 has been demonstrated by eruption of inflammatory insulitis
upon IL-2 neutralization [29] and consistently, a beneficial effect
of IL-2 administration over disease progression [30]. In general,
naı ¨ve/effector T cells supply this cytokine and Treg consume it
avidly, creating a cycle of reciprocal dependence on IL-2: Treg
inhibit cytokine production limiting the activity of cytotoxic T
cells, and in turn IL-2 deficiency downsizes the activity of Treg
[26]. Whereas exogenous IL-2 does not affect significantly Fas-
mediated apoptosis of CD25
2 and FoxP3
2 T cells, exposure of
mixed cultures to 2000 U/ml IL-2 decreases Treg apoptosis in
NOD and wild type CD25
+ T cells (Figure 2A). Notably,
spontaneous and Fas-mediated apoptosis under the influence of
IL-2 is comparable in wild type and NOD mice. IL-2 stimulates
faster cycling rates in CD25
+ T cells from NOD mice (Figure 2B),
possibly because the relative IL-2 insufficiency in these mice in vivo
[30]. The correlation between proliferation and increased
susceptibility to Fas-mediated apoptosis is basic feature of AICD
in naı ¨ve/effector CD25
2 T cells [31–33]. In variance, mitogenic
stimulation with ConA shows dissociation between proliferation
and sensitivity to Fas-mediated apoptosis in CD25
+ Treg
(Figure 2C), indicating that decreased apoptosis under IL-2
stimulation was partially caused by robust expansion of viable
cells.
Fas cross-linking does not abolish the suppressive
activity of CD25
+ T cells
We have recently reported that adoptive transfer of CD25
+ T
cells overexpressing FasL protein delays onset and reduces
incidence of overt hyperglycemia in prediabetic NOD mice [34].
The current data indicate high sensitivity of these cells to Fas cross-
linking during extended in vitro culture, questioning the impact of
Fas cross linking on the suppressive activity of this subset. To
determine how AICD affects the suppressor activity, isolated
CD25
+ T cells were exposed to FasL for 48 hours prior to
conincubation with strain-matched CFSE-labeled CD25
2 T cells
under CD/CD28 stimulation. Notably, CD25
2 T cells display
similar responses to CD3/CD28 stimulation in NOD and wild
type mice (vide infra). Viable CD25
+ T cells from wild type and
NOD mice had similar suppressive effects on the proliferation of
stimulated responders from the respective strains (Figure 3A),
emphasizing sustained regulatory activity of CD25
+ T cells that
survive the FasL challenge.
Autocrine apoptosis reduces the diabetogenic activity of
effector T cells in vivo
To assess the physiological significance of effector T cell
sensitivity to apoptosis, FasL chimeric protein was adsorbed on the
surface of CD25
2 T cells adoptively transferred into NOD.SCID
mice. Infusion of FasL-coated CD4
+CD25
2 T cells decreased the
efficacy of disease transfer and delayed the mean onset time
(MOT) to 1261.9 weeks as compared to 9.563.6 weeks in
recipients of naı ¨ve CD25
2 cells (p,0.05, Figure 3B). Reduced
disease incidence was accompanied by a corresponding decrease
in inflammatory islet score, indicating that the diabetogenic
potential is reduced by Fas cross linking in vivo as previously
demonstrated for exposure to FasL ex vivo [21,35]. These data also
demonstrate limited toxicity of ectopic FasL protein to the islets
[34], an apoptotic pathway that is largely dispensable in the
process of destructive autoimmune insulitis [36]. Despite the
marked variations in disease onset and incidence, the similar CD4
+
profiles of mesenteric/pancreatic lymph nodes of NOD.SCID
recipients of naı ¨ve and FasL-coated CD25
2 T cells (Figure 3C)
suggests that the apoptotic pathways affects primarily the islet
Sensitivity to Fas Apoptosis in NOD Mice
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has been observed when CD25
2 T cells were co-adoptively
transferred with FasL-coated CD25
+ Treg into NOD.SCID mice
[34]. Altogether these data underlie the flexibility of CD25
2 T
cells in repopulating NOD.SCID mice to reinstate immune
homeostasis in NOD.SCID mice through generation of regulatory
subsets.
Sensitivity to apoptosis under TCR-associated stimulation
and costimulation
In next stage we considered that differential susceptibility of
effector T cells in NOD mice might be restricted to conditions of
stimulation under inflammatory environments. To assess the
sensitivity to Fas-mediated apoptosis, CD4
+CD25
2 and
CD4
+FoxP3
2 effector T cells were further characterized under
CD3 and CD28 stimulation, which induces robust proliferation
and upregulates CD25 expression (Figure 4A). In order to measure
apoptosis in mixed cultures, we considered that upregulation of
CD25 in the majority of CD25
2 T cells (CD25
2RCD25
+)
dominates the insignificant minor fraction (,10%) of naturally
occurring CD25
+ T cells. Comparative analysis reveals reduced
responsiveness of NOD lymphocytes to CD3 stimulation,
including both upregulation of CD25 (p,0.01, Figure 4A) and
proliferation (p,0.05, Figure 4B), which is compensated by
additional CD28 costimulation. Reduced proliferation rates of
NOD lymphocytes under CD3 activation suggest lesser respon-
siveness to TCR-associated stimulation due to a higher intrinsic
state of activation associated with autoimmune inflammation. Fast
cycling rates of CD25
2 T cells that upregulate CD25 expression
under CD3 and CD3/CD28 stimulation reduce fractional
apoptosis, whereas cells with sustained CD25
2 phenotype display
high levels of FasL-induced apoptosis (Figure 4C). Reduced levels
of apoptosis caused by fast cycling of viable cells was confirmed by
inhibition of cell proliferation with Mitomycin C, which increased
Figure 1. Sensitivity of naı ¨ve/effector CD4
+ T to Fas-mediated apoptosis. A. Apoptosis of splenocytes from prediabetic NOD females (14
weeks) during 48 hours of incubation in control medium and induced by 50 mg/ml FasL. Isolated CD4
+CD25
2 and CD4
+CD25
+ T cell subsets (n=5)
are compared to measurements performed by gating in mixed splenocyte cultures (n=7). Representative measurements of apoptosis and death
assessed by incorporation of Annexin-V and 7-AAD respectively, in isolated and gated CD4
+ T cell subsets. B–C. Apoptosis of gated naı ¨ve/effector
CD25
2 and FoxP3
2 subsets (B) and CD25
+ and FoxP3
+ Treg (C) in mixed cultures of splenocytes from prediabetic NOD females (n=5), wild type mice
(C57/BL, n=7) and Foxp3-GFP transgenes (n=5) during 48 hours of incubation in control medium and with 50 mg/ml FasL. The plots of present
apoptosis in gated CD4
+CD25
+ and CD4
+FoxP3-GFP
+ cells.
doi:10.1371/journal.pone.0021630.g001
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to Fas cross-linking demonstrate that TCR-associated activation
and costimulation do not perturb a balanced negative regulation of
the naı ¨ve/effector lymphocytes in NOD mice.
In variance from CD25 upregulation, FoxP3 is not induced by
CD3 and CD28 stimulation, allowing measurements of apoptosis
of CD4
+FoxP3
2 and CD4
+FoxP3
+ T cells in mixed cultures of
splencoytes from FoxP3-GFP transgenes (Figure 5A). Both
FoxP3
2 effector (Figure 5B) and FoxP3
+ Treg subsets (Figure 5C)
display reduced susceptibility to spontaneous apoptosis and
sensitivity to Fas cross-linking under CD3 and CD3/CD28
stimulation, indicating sustained viability by TCR-associated
activation and costimulation. Under such conditions the Treg
subset appears to benefit of superior viability (p,0.01), consistent
with activation of suppressor mechanisms in early stages of
immune activation by reduced sensitivity to AICD-type negative
regulation.
Discussion
Among multiple pathways of immune deregulation, anomalies
of T cell sensitivity to apoptosis are considered to contribute to
eruption of diabetes in NOD mice [15–17]. The proposed
scenario of perturbed immune homeostasis in diabetes-prone mice
Figure 2. Impact of IL-2 on CD25
+ T cell sensitivity to apoptosis and proliferation. A. Apoptosis of gated CD4
+CD25
+ subsets in NOD (n=5)
and wild type mice (n=7) and CD4
+FoxP3
+ T cells in wild type mice (n=6) during 48 hours of incubation with supplementation of 2000 U/ml IL-2 (IL-
2) and with 50 mg/ml FasL (IL-2 FasL) as compared to apoptosis in response to FasL in control medium (FasL). Demonstrative measurements of
apoptosis and death assessed by incorporation of Annexin-V and 7-AAD respectively. B. Fas-mediated apoptosis of CD4
+CD25
+ T cells from NOD and
wild type mice as a function of proliferation rates measured from CFSE dilution, with (n=4–5) and without (n=5–7) exogenous supplementation of
IL-2 (n=4–5). C. Apoptosis of gated CD4
+CD25
2 and CD4
+CD25
+ subsets induced by Fas cross-linking under mitogenic stimulation with ConA in NOD
(n=4) and wild type mice (n=5).
doi:10.1371/journal.pone.0021630.g002
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in part due to deficient expression of the Fas receptor [37], and
increased susceptibility of suppressor cells to apoptotic death
[38–40]. In this study we provide evidence that Treg are submitted
to clonal deletion by Fas cross-linking, and peripheral AICD
negative regulation of T cells is largely intact in NOD mice in
advanced stages of inflammatory insulitis. Therefore, neither
resistance of effector cells nor sensitivity of regulatory cells to
AICD-type negative regulation predispose to evolution of
autoimmune insulitis.
Treg are extremely sensitive to their environment. These cells
operate primarily at the site of inflammation within a dynamic
environment influenced by cytotoxic T cells as well as tissue injury
[28], including a series of feedback mechanisms that modulate their
activity [41–44]. Therefore, assessment of sensitivities to spontane-
ous and Fas-mediated apoptosis in suspensions of purified T cell
subsets is unlikely to reflect a true behavior [19,27]. For example,
proliferative anergy characteristic of purified Treg in vitro is in sharp
contrast from the faster proliferation rates of these cells in vivo
[24,25,43,44]. Likewise, purified CD25
+ cells display excessive
sensitivity to spontaneous apoptosis in culture [20,22–24], which is
common to wild type, prediabetic and diabetic NOD females [27].
Considering mixed cultures as a better model to assess AICD
[19,25,27], it is evident that both anti- and pro-apoptotic signals
originate from adjacent cells. On the one hand, increased
spontaneous apoptosis of CD25
+ T cells is reversed in mixed
cultures [27], underlining the provision of anti-apoptotic factors and
signals by other cell subsets. On the other hand, apoptosis triggered
by Fas cross-linking is amplified in mixed cultures, disclosing the
presence of proapoptotic factors that augment AICD-type negative
regulationin both subsets. Herewe emphasizethat Fas cross-linking
is a homeostatic mechanism of negative regulation of naturally
occurring Treg.
Cytokine deprivation has profound effects on the sensitivities to
apoptosis of both effector [45] and suppressor subsets [46]. IL-2 is
a major cytokine associated with cell viability, as demonstrated by
the reduced intrinsic sensitivity to apoptosis of lymphocytes
deficient in IL-2 and its cognate receptors [31–33,47,48].
Naturally occurring Treg are avid consumers of IL-2 but do not
produce this cytokine [49], which modulates both effector and
Figure 3. Impact of FasL on effector and regulatory T cell activity. A. Inhibition of proliferation of CFSE-labeled CD25
2 T cell responders
activated with CD3/CD28 (control) by CD25
+ T cells isolated from NOD and wild type mice after incubation with FasL at a Teff:Treg ratio of 3:1. Data
are representative of four experiments in which CD25
+ suppressor cells were co-incubated with CFSE-labeled CD25
2 responders from the same
strain. B. NOD.SCID mice were adoptively transferred with 2.5610
7 naı ¨ve (n=36) and FasL-coated CD25
2 T cells (n=12) from prediabetic NOD
females. Blood glucose was monitored to determine onset of diabetes at levels .200 mg/dl. C. Fractional expression of CD25 and FoxP3 in CD4
+ T
cells from mesenteric/pancreatic lymph nodes of NOD.SCID mice reconstituted with naı ¨ve (n=6) and FasL-coated (n=5) CD25
2 T cells from
prediabetic NOD females.
doi:10.1371/journal.pone.0021630.g003
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sensitization to apoptosis of CD25
2 naı ¨ve/effector T cells by IL-2
[31–33], proliferation and sensitivity to FasL are dissociated in
CD25
+ Treg: IL-2 causes dilution of dead cells due to robust
expansion of viable cells. Uncoupling between proliferation and
Fas-dependent negative regulation evolves as a particular Treg
characteristic, which maintains viability of this subset with intrinsic
state of activated suppressor activity under steady state conditions
[28,44]. Furthermore, TCR-associated stimulation independently
protects Treg from apoptosis, exceeding its effect on naı ¨ve/effector
cells. Considering that TCR engagement is essential to initiate
Treg cycling under IL-2 stimulation [26,51], both stimulatory
pathways are shown to support the function and viability of
regulatory T cells.
Naı ¨ve/effector cells from wild type and NOD mice display
similar sensitivities to Fas cross-linking under TCR-associated
activation and CD28 costimulation in mixed cultures, including
the subset induced into fast proliferation that upregulates CD25
expression. Our data corroborate the observation that sensitivity
to apoptosis under CD28 costimulation is not entirely dependent
on Fas cross-linking [19,52] and demonstrates the reciprocal
condition where this apoptotic pathway operates independent of
costimulation. Whereas CD28 costimulation superposed on CD3
activation increases the susceptibility of naı ¨ve/effector T cells to
spontaneous apoptosis [27], it does not sensitize these cells to Fas
cross-linking. Thus, exacerbation of diabetes by CD28 deficiency
in NOD mice [52] and the reciprocal protection by CD28
costimulation in neonatal NOD [53] and T cell depletion with
Figure 4. Sensitivity to apoptosis under CD3 and CD3/CD28 stimulation. A. Representative plots of CD25 upregulation under CD3
stimulation in splenocytes from NOD and wild type mice. Quantitative conversion to express CD25 in splenocyte cultures from NOD (n=4) and wild
type females (n=6) under CD3 and CD3/CD28 stimulation as compared to unstimulated cultures (naı ¨ve). Other delineates all CD4
2 cells. B.
Proliferation rates of CD4
+ T cells that upregulated CD25 expression (CD25
2RCD25
+) as determined from CFSE dilution in mixed cultures of
splenocytes from NOD (n-4) and wild type mice (n=5) under CD3 and CD3/CD28 stimulation. C. FasL-induced apoptosis in reference to CD25
expression in gated CD4
+ T cells within mixed splenocyte cultures from NOD and wild type mice (n=4) under CD3/CD28 stimulation. Apoptosis was
also measured under inhibition of proliferation with Mitomycin C (n=3).
doi:10.1371/journal.pone.0021630.g004
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responsible for immunomodulation.
Among multiple mechanisms of immune deregulation in NOD
mice, there is no evidence of defective peripheral negative
regulation and dysfunctional AICD as predisposing factors in
evolution of inflammatory insulitis. Inasmuch as immune dereg-
ulation is attributed to aberrant sensitivity to Treg-mediated
suppression of effector cells in NOD mice [3–5] and humans [55],
our data present evidence of protracted negative regulation of
naı ¨ve/effector CD4
+ T cells under stimulatory conditions.
Balanced AICD-type negative regulation of effector and suppres-
sor cells in wild type and NOD mice is consistent with similar
distribution of CD4
+ subsets under steady state conditions as well
as in reconstituted NOD.SCID mice. The diabetogenic potential is
impaired by overexpression of FasL on CD25
2 cells, similar to the
inhibitory activity of this apoptotic pathway in lymphocytes of
diabetic NOD mice in vitro [35]. Whereas the Fas receptor is
evenly expressed by effector and suppressor subsets, exclusive
expression of the cognate ligand in CD25
2 cells suggests auocrine
and paracrine (fratricide) negative regulation of diabetogenic and
suppressor clones within the inflammatory infiltrates and regional
lymphatics [21]. Notably, FasL is dispensable in the process of
destructive inflammatory insulitis [36] and does not impose severe
threat to naı ¨ve islets from NOD and wild type mice [34,56] unless
expressed as a transgene in b cells [57], therefore it can be used for
immunomodulation in both transplant and autoimmune settings
[14,34,58].
A significant difference in the naı ¨ve/effector subset of T cells is
the slower proliferation in response to mitogenic CD3 ligation in
NOD mice, which is restored by CD28 costimulation. Effector
cells in NOD mice are also less sensitive to radiation [59], resulting
in disease recurrence upon recovery from immunosuppression
[60], enhanced bone marrow allograft rejection [61] and persistent
autoimmune insulitis even in the absence of alloreactivity [59,62].
In the transplant setting, perturbed homeostasis during recovery
from conditioning-induced lymphopenia contributes to disease
recurrence [63] unless negative regulation is restored by mixed
allogeneic chimerism [64]. In addition, the effect of IL-2 on Treg
in NOD mice appears to be more pronounced, consistent with an
intrinsic state of activation concurrent with the ongoing inflam-
matory state [28] that is characterized by relative IL-2
insufficiency [30]. Although IL-2 is a significant factor in
sustaining Treg resistance to apoptosis, as also demonstrated in
isolated CD25
+ T cell suspensions [27], this cytokine and its
relative deficiency do not cause aberrant clonal deletion in NOD
mice. On the contrary, support of Treg viability is an apparent
mechanism that participates in amelioration of inflammatory
insulitis by IL-2 administration [30,65].
In summary, we demonstrate: a) Treg are submitted to AICD-
type regulation mediated by Fas cross-linking, b) proliferation and
sensitivity to Fas-mediated AICD are dissociated in Treg, c)
effective clonal deletion of both subsets under stimulatory
conditions, d) balanced sensitivity to negative regulation of effector
and suppressor CD4
+ T cells, and e) insignificant differences in
AICD-type negative regulation between wild type and NOD mice.
Altogether these data indicate that negative regulation though
apoptosis is not a major factor that predisposes to immune
deregulation and evolution of autoimmune insulitis in NOD mice.
Materials and Methods
Animals
Mice used in this study were C57BL/6 (wild type), non-obese
diabetic (NOD) and B6.Cg-Foxp3
tm2Tch transgenic mice (express-
ing GFP under control of the FoxP3 promoter). Animals
purchased from Jackson Laboratories (Bar Harbor, ME) were
inbred and housed in a barrier facility. The Institutional Animal
Care Committee of the Schneider Medical Center has approved
all procedures #022B6229 dated 4.1.2009. Blood glucose was
monitored between 9–11 AM in tail blood samples at weekly
intervals using a glucometer (Accu-Chek Sensor, Roche Diagnos-
tics, USA). Diabetes was defined as two consecutive blood glucose
measurements above 200 mg/dl [59].
Figure 5. Sensitivity to apoptosis under stimulation in reference to FoxP3 expression. A. CD4
+ T cells do not upregulated FoxP3
expression under CD3/CD28 stimulation in mixed splenocyte cultures from FoxP3-GFP transgenes. Apoptosis was determined in control medium and
with FasL under CD3 and CD3/CD28 stimulation in (B) gated FoxP3
2 T cells (n=5) and (C) gated FoxP3
+ T cells (n=6) in mixed cultures of splenocytes
from transgenic FoxP3-GFP mice.
doi:10.1371/journal.pone.0021630.g005
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Cell suspensions from spleens and lymph nodes were prepared as
previously reported [5,59]. CD25
2 and CD25
+ subsets of CD4
+ T
cells areisolated from the spleens and mesenteric lymph nodes using
the CD4
+CD25
+ Regulatory T cell isolation kit (Miltenyi Biotec,
Bergisch-Gladbach, Germany) [5]. Briefly, CD4
+ T cells are
negatively selected and positive CD25
+ selection was performed
using PE-labeled monoclonal antibodies conjugated to anti-PE
magnetic microbeads, which were retained during passage through
a magnetic field. Immunomagnetic isolation of cells from NOD
females yields a CD4
+CD25
2 subset contaminated with 0.760.4%
and 3.661.3% CD25
+ and FoxP3
+ cells respectively, and a
CD4
+CD25
+ subset of which 7564% expressed FoxP3, and are
contaminated with 1768% CD25
2/low cells.
Flow cytometry
Cells composition was determined using antibodies conjugated
to fluorescein isothyocyanite (FITC), phycoerythrin (PE), allophy-
cocyanin (APC) and peridinin chlorophyll a-protein (PerCP, BD
Pharmingen, San Diego, CA): CD4 (clone RM 4-5), CD8 (clone
53-6.7), CD25 (clone PC61.5) [5,27]. FoxP3 was determined
following permeabilization and intracellular staining with a PE-
labeled antibody (Foxp3 staining buffer set NRRF-30, eBioscience,
San Diego, CA). Antibodies were purchased from BD Pharmingen
and eBioscience. Cell death and apoptosis were determined in cells
incubated with 5 mg/ml 7-aminoactinomycin-D (7-AAD, Sigma,
St. Lois, MO) and Annexin-V (IQ products, Groningen, The
Netherlands), respectively. Measurements were performed with a
Vantage SE flow cytometer (Becton Dickinson, Franklin Lakes,
NJ). Positive staining was determined on a log scale, normalized
with control cells stained with isotype control antibodies.
In vitro apoptosis
2610
6 cells/ml were incubated in DMEM supplemented with
2 mM L-glutamine, 1 mM sodium pyruvate, 13.6 mM folic acid,
270 mM L-asparagine, 548 mM L-arginine HCL, 10 mM HEPES,
50 mM2 b-Mercaptoethanol, 100 mg/ml streptomycin, 100 U/ml
penicillin and 5% heat-inactivated fetal bovine serum (FBS) (MLR
medium) [60]. All ingredients were purchased from Beit Haemek
and Sigma (St. Lois, MO). Apoptotic challenge was applied by
addition of 50 mg/ml FasL chimeric protein. Cells were stimulated
by exogenous supplementation of 2000 U/ml IL-2 (Peprotech,
London, UK), anti-CD3 (R&D Systems, Minneapolis, MN) and
beads conjugated to anti-CD3 and anti-CD28 (Invitrogen, Oslo,
Norway) at a bead:cell ratio of 1:1. For determination of apoptosis
in reference to FoxP3 expression, cells were first exposed to
Annexin-V and subsequently were stained for FoxP3 expression.
Proliferation assay
Splenocytes and lymphocytes were incubated at room temper-
ature for 7 minutes with 10 mM 5-(and 6-)-carboxyfluorescein
diacetate succinimidyl ester (CFSE, Molecular Probes, Carlsbad,
CA) [27]. The labeled responders were cultured at 37uCi na
humidified 5% CO2 atmosphere for 2 days in MLR medium
containing 5% heat-inactivated mouse serum and 20 U/ml IL-2.
All proliferation assays were performed in triplicates. Suppression
of proliferation of CFSE-labeled responders stimulated with CD3/
CD28 was performed by co-culture with isolated CD25
+ T cells at
various Teff:Treg ratios for 48 hours. CFSE dilution was analyzed
in flow cytometry by gating on the live lymphocytes and
proliferation was quantified with ModFit software (Verity Software
House, Topsham, ME).
Adsorption of FasL protein on cell surface
Splenocytes harvested under aseptic conditions were suspended
in 5 mM freshly prepared EZ-Link Sulfo-NHS-LC-Biotin (Pierce)
in PBS for 30 minutes at room temperature [66]. Washed cells
were incubated with streptavidin-FasL chimeric protein (100 ng
protein/1610
6 cells in PBS). After two additional washes the
efficiency of adsorption was evaluated by flow cytometry using
anti-streptavidin and anti-FasL antibodies.
Histology
Pancreata were excised from mice euthanized by CO2
asphyxiation, and were fixed in ice-cold PBS containing 1.5%
fresh paraformaldehyde for 2 hours at 0–4uC before overnight
immersion in 30% sucrose [59]. Tissues were embedded in OCT
(Sakura Finetek, Torrance, CA), frozen in isopentane suspended in
liquid nitrogen, sectioned (3–6 mm) with a Cryotome (Thermo
Shandon, Cheshire, UK) and stained with hematoxylin and eosin.
Islet inflammation was scored according to: 0-no inflammation, 1-
peri-insulitis, 2-inflammatory infiltration ,50% of islet area, 3-
inflammation .50% of islet area and 4- disruption of islet
structure.
Statistical analysis
Data are presented as means 6 standard deviations for each
experimental protocol. Results in each experimental group were
evaluated for reproducibility by linear regression of duplicate
measurements. Differences between the experimental protocols
were estimated with a post hoc Scheffe t-test and significance was
considered at p,0.05.
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